(Q53518457)
Statements
High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas. (English)
Giovanni Martinelli
1 reference
Anna Vanazzi
Chiara M Grana
Marta Cremonesi
Mirco Bartolomei
Marco Chinol
Mahila Ferrari
Davide Radice
Stefano Papi
1 November 2007
139
4
590-599
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference